MARC VISCOGLIOSI
CEO,
Spine Biopharma
United States
Marc Viscogliosi is an experienced CEO, Venture & Private Equity Investor and Company/Industry Creator with a proven track record of success in the medical technology industry.
Throughout his 25+-year career, Mr. Viscogliosi has completed over $1 billion in equity and debt capital raises at all levels of a company’s lifecycle, while generating over $2.7 billion in exit value proceeds for investor-partners and stakeholders. With over two dozen issued medical device patents, several FDA PMA Approvals and leading products through the AMA CPT Coding and Payer Coverage Policy development processes, Mr. Viscogliosi has consistently shepherded start-ups into high-growth, high-performance organizations.
In 1999, Mr. Viscogliosi, with his brothers Anthony and John, co-founded Viscogliosi Brothers, LLC (“VB”), a family office focused on investing its own capital, alongside that of its partners, as direct investments into musculoskeletal companies. VB and its partners have invested in 30 companies that have resulted in 18 exits and $2.7 billion in distributable proceeds. Mr. Viscogliosi has founded and led several musculoskeletal companies, including Spine BioPharma, Paradigm Spine, Knee Creations, and MCRA.
Mr. Viscogliosi began his career as a Wall Street institutional equity sell-side research analyst, covering the neuro-musculoskeletal industry from 1992 to 1999.
Sessions
-
10-Feb-2025Spine BioPharma
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}